NASDAQ:HALO | Operating Margin | HALOZYME THERAPEUTICS, INC.

Complete source-backed operating margin history.

Available history
2009-12-31 to 2026-06-30
Data captured

Historical Operating Margin

DateOperating Margin
2026-06-3059.80%
2026-03-3148.98%
2025-12-31-20.56%
2025-09-3061.51%
2025-06-3062.15%
2025-03-3153.44%
2024-12-3158.89%
2024-09-3056.26%
2024-06-3050.67%
2024-03-3148.78%
2023-12-3143.92%
2023-09-3040.86%
2023-06-3042.73%
2023-03-3133.18%
2022-12-3141.05%
2022-09-3039.86%
2022-06-3022.35%
2022-03-3164.52%
2021-12-3155.42%
2021-09-3065.26%
2021-06-3068.19%
2021-03-3156.99%
2020-12-3163.78%
2020-09-3061.70%
2020-06-3053.52%
2020-03-31-12.71%
2019-12-31-59.74%
2019-09-30-53.08%
2019-06-30-35.70%
2019-03-315.21%
2018-12-31-0.12%
2018-09-30-99.68%
2018-06-30-57.02%
2018-03-31-76.81%
2017-12-3166.43%
2017-09-3012.67%
2017-06-30-75.49%
2017-03-31-93.09%
2016-12-31-57.88%
2016-09-30-71.40%
2016-06-30-65.16%
2016-03-31-38.05%
2015-12-3110.46%
2015-09-30-111.82%
2015-06-309.75%
2015-03-31-74.53%
2014-12-31-12.68%
2014-09-30-130.26%
2014-06-30-81.26%
2014-03-31-210.76%
2013-12-31-170.62%
2013-09-30-115.49%
2013-06-30-153.04%
2013-03-31-156.29%
2012-12-31-20.22%
2012-09-30-375.49%
2012-06-30-181.10%
2012-03-31-203.50%
2011-12-31-764.28%
2011-09-3022.46%
2011-06-3013.35%
2011-03-31-128.05%
2010-12-31-500.59%
2010-09-30-366.07%
2010-06-30-378.17%

Annual Operating Margin

DateOperating Margin
2025-12-3133.58%
2024-12-3154.32%
2023-12-3140.71%
2022-12-3140.53%
2021-12-3162.24%
2020-12-3153.91%
2019-12-31-34.50%
2018-12-31-45.65%
2017-12-3125.58%
2016-12-31-56.72%
2015-12-31-20.33%
2014-12-31-83.68%
2013-12-31-146.78%
2012-12-31-126.70%
2011-12-31-35.37%
2010-12-31-398.25%
2009-12-31-427.60%